$NAMS

Newamsterdam Pharma Faces Revenue Challenges And Celebrates Clinical Trial Successes

$NAMS In a recent financial update, NewAmsterdam Pharma Company NV (NASDAQ:NAMS) experienced a notable revision in its revenue forecasts, which…